| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6096339 | PFIZER | Dosage form, process of making and using same |
Apr, 2017
(7 years ago) | |
Covera-Hs is owned by Pfizer.
Covera-Hs contains Verapamil Hydrochloride.
Covera-Hs has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Covera-Hs are:
- US6096339
Covera-Hs was authorised for market use on 26 February, 1996.
Covera-Hs is available in tablet, extended release;oral dosage forms.
Covera-Hs can be used as method for the treatment of cardiovascular disease through the administration of a calcium blocking vasodilator in our extended, controlled release formulation.
The generics of Covera-Hs are possible to be released after 04 April, 2017.
Drugs and Companies using VERAPAMIL HYDROCHLORIDE ingredient
Market Authorisation Date: 26 February, 1996
Treatment: Method for the treatment of cardiovascular disease through the administration of a calcium blocking vasodilator in our extended, controlled release formulation
Dosage: TABLET, EXTENDED RELEASE;ORAL
COVERA-HS family patents
